EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.1.55 | Homo sapiens | - |
individuals with frailty (cognitive impairment) scores from 0.10 (young/healthy) up to 4.47 | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.1.55 | blood plasma | venous blood, similar aspirin esterase activity in frailty phenotype as in young/healthy phenotype | Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.1.1.55 | additional information | - |
125 nmol/min/ml plasma, day hospital patients: intermediate frailty phenotype (frailty score: 2.97), average age: 84.2 years | Homo sapiens |
3.1.1.55 | additional information | - |
64 nmol/min/ml plasma, continuing, long-term care patients: frailty phenotype (frailty score: 4.47), average age: 84.9 years | Homo sapiens |
3.1.1.55 | additional information | - |
82 nmol/min/ml plasma, young/healthy phenotype control (frailty score: 0.10), Caucasian, average age: 23.2 years | Homo sapiens |
3.1.1.55 | additional information | - |
84 nmol/min/ml plasma, independent and age-matched controls (frailty score: 0.83), average age: 82.7 years | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.1.55 | acetylsalicylic acid + H2O | 20 min | Homo sapiens | salicylate + acetate | analysis and quantification of salicylate at 300 nm | ? | |
3.1.1.55 | additional information | no correlation between aspirin esterase activity and frailty phenotype, interleukin-6, tumour necrosis factor-alpha, or C-reactive protein | Homo sapiens | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.1.55 | aspirin esterase | - |
Homo sapiens |
3.1.1.55 | plasma aspirin esterase | - |
Homo sapiens |